Nuzenio

Seres Therapeutics

Seres Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 15:13:05 GMTSeres Therapeutics Inc (MCRB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Wed, 05 Aug 2026 21:16:00 GMTSeres Therapeutics exits more Cambridge real estate early - The Business Journals
Wed, 05 Aug 2026 15:28:36 GMTSeres Therapeutics Q2 Operating Income USD -2 - Moomoo
Wed, 05 Aug 2026 14:41:21 GMTSeres Therapeutics, Inc. 2Q 2026: Revenue $0.736M, Net income $4.581M, EPS $0.47— 10-Q Summary - TradingView
Wed, 05 Aug 2026 13:13:24 GMTSeres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Wed, 05 Aug 2026 13:03:49 GMTSeres Therapeutics (MCRB) Q2 Revenue Surpasses Expectations Amid Clinical Progress - GuruFocus

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Seres Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.